CATALYST DOSSIER · UPDATED 2026-11-05
$CRIS
biotech · convergence 26 · conviction ELEVATED
Price & Live Quote Loading live quote & chart…
Practice trade tools Build a reference frame, save a practice trade, or preview a draft. No brokerage order is placed.
Paper trade unavailable: missing risk-bounded frame
Reference only. Not financial advice. No brokerage order is placed.
Why $CRIS?
Quantitative
Net Income (CY2026Q2) : $-8.6M (+14.0% YoY)
Catalysts
Multi-spoke convergence : 12 convergent signals fired: earnings, regsho, finra_short, gap, finra_regsho
Risks
Hard-to-borrow / FTD risk : Borrow rate 6.0%, distress score 30
Reg SHO threshold list : On NASDAQ threshold list (2026-11-04)
Bear case
Squeeze unwind : Short interest can compress before retail catches the move — entry timing critical
Earnings binary : Print-day moves can swing ±15% — gap risk both directions
Sympathy basket (cerebro)
APP via tech r=+0.81 sympathetic (score 19)
STEM via tech r=+0.81 sympathetic (score 19)
LBTYA via comms r=+0.62 sympathetic (score 16)
CHTR via comms r=+0.62 sympathetic (score 7)
Signals Firing
earnings regsho finra_short gap finra_regsho sec_fda pill orderbook auto_sec_poison_pill auto_macro_adp_payrolls auto_macro_durable_goods auto_macro_fx_rates
Pick Track Record Date List Next-day max run Next-day close Hit +2%? 2026-11-03 sec_top_gappers +125.4% +56.3% ✓ hit 2026-11-03 sec_top_moat_emerging +125.4% +56.3% ✓ hit 2026-10-27 sec_top_gappers +12.5% +12.5% ✓ hit 2026-10-27 sec_top_moat_emerging +12.5% +12.5% ✓ hit 2026-10-26 sec_top_gappers +7.9% +5.3% ✓ hit 2026-10-26 sec_top_moat_emerging +7.9% +5.3% ✓ hit 2026-10-23 sec_top_gappers +5.1% -2.6% ✓ hit 2026-10-23 sec_top_moat_emerging +5.1% -2.6% ✓ hit 2026-10-19 sec_top_gappers +7.9% +5.3% ✓ hit 2026-10-19 sec_top_moat_emerging +7.9% +5.3% ✓ hit
Lifetime: 10/10 wins · hit-rate 100.0% on +2% intraday
Sympathy Basket APP via tech · score 19 STEM via tech · score 19 LBTYA via comms · score 16 CHTR via comms · score 7
Earnings Catalyst No recent earnings event.
Generate full earnings report
Auto-generated from public filings + tier-1 wires. Catalyst Edge publishes its picks
and its losses — see the
trust report and
methodology .
Not financial advice. Confirm independently before trading.